Skip to content
Screener

EyePoint, Inc. EYPT Current ratio

Current ratio at other companies

Merck & Co. logo
Merck & Co.MRK
1.3×-0.1×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
3.3×-1.3×
Ocular Therapeutix logo
Ocular TherapeutixOCUL
14.8×+4.6×
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
3.5×-1.1×
Regenxbio logo
RegenxbioRGNX
2.9×-0.3×
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
9.3×-3.0×

Other financials

Income statement

See full
Revenue$507.0K-90.5%
Gross profit$9.8M-30.1%
Operating income-$97.4M-56.5%
Net income-$94.5M-59.0%
EPS (diluted)-$1.09-28.2%

Balance sheet

See full
Cash & equivalents$110.5M+55.3%
Total debt$22.4M-5.7%
Total equity$166.4M-32.4%
Total assets$228.2M-24.2%

Cash flow

See full
Operating cash flow-$62.3M+0.4%
CapEx$1.2M-1.6%
Free cash flow-$63.5M+0.4%

Valuation

See full
Market cap$1.11B+51.9%
Enterprise value$1.02B+49.6%
P/S396.6×+383×

Profitability

See full
Operating margin-11,365.2%-11,754pp
Net margin-10,994.7%-11,355pp
FCF margin-9,726.7%-10,132pp

Returns & leverage

See full
Return on equity-148.7%-13,871pp
Debt / equity0.1×0.0×

Where this comes from

Calculated from EyePoint, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: EyePoint, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335037

FAQ

What is EyePoint, Inc.'s current ratio?
EyePoint, Inc. (EYPT) reported current ratio of 4.5× in Q2 2026.
How has EyePoint, Inc.'s current ratio changed year-over-year?
EyePoint, Inc.'s current ratio decreased by 43.7% year-over-year, from 8× to 4.5×.
What is the long-term trend for EyePoint, Inc.'s current ratio?
Over 5 years (2020 to 2025), EyePoint, Inc.'s current ratio has grown at a 15.9% compound annual growth rate (CAGR), from 4.2× to 8.9×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Ask your AI about EyePoint, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude